209 related articles for article (PubMed ID: 32649846)
1. Developmental process in diffuse psychological/neuropsychiatric manifestations of neuropsychiatric systemic lupus erythematosus.
Arinuma Y; Yamaoka K
Immunol Med; 2021 Mar; 44(1):16-22. PubMed ID: 32649846
[TBL] [Abstract][Full Text] [Related]
2. What are the latest clinical findings regarding the association of neurotoxic brain antibodies found in the cerebrospinal fluid in patients with autoimmune disorders?
Arinuma Y
Curr Opin Neurol; 2020 Jun; 33(3):347-352. PubMed ID: 32251024
[TBL] [Abstract][Full Text] [Related]
3. Blood-brain barrier damages and intrathecal synthesis of anti-N-methyl-D-aspartate receptor NR2 antibodies in diffuse psychiatric/neuropsychological syndromes in systemic lupus erythematosus.
Hirohata S; Arinuma Y; Yanagida T; Yoshio T
Arthritis Res Ther; 2014 Mar; 16(2):R77. PubMed ID: 24655341
[TBL] [Abstract][Full Text] [Related]
4. Association of cerebrospinal fluid anti-Sm antibodies with acute confusional state in systemic lupus erythematosus.
Hirohata S; Sakuma Y; Yanagida T; Yoshio T
Arthritis Res Ther; 2014 Oct; 16(5):450. PubMed ID: 25273532
[TBL] [Abstract][Full Text] [Related]
5. Clinical significance of anti-DNA/N-methyl-D-aspartate receptor 2 antibodies in de novo and post-steroid cases with neuropsychiatric systemic lupus erythematosus.
Fujieda Y; Mader S; Jeganathan V; Arinuma Y; Shimizu Y; Kato M; Oku K; Minami A; Shimizu C; Yasuda S; Atsumi T
Int J Rheum Dis; 2019 Mar; 22(3):443-448. PubMed ID: 30358102
[TBL] [Abstract][Full Text] [Related]
6. Association of antibodies to the NR1 subunit of N-methyl-D-aspartate receptors with neuropsychiatric systemic lupus erythematosus.
Ogawa E; Nagai T; Sakuma Y; Arinuma Y; Hirohata S
Mod Rheumatol; 2016; 26(3):377-83. PubMed ID: 26429674
[TBL] [Abstract][Full Text] [Related]
7. Autoantibodies involved in neuropsychiatric manifestations associated with systemic lupus erythematosus: a systematic review.
Sciascia S; Bertolaccini ML; Roccatello D; Khamashta MA; Sanna G
J Neurol; 2014 Sep; 261(9):1706-14. PubMed ID: 24952022
[TBL] [Abstract][Full Text] [Related]
8. Autoantibodies associated with neuropsychiatric systemic lupus erythematosus: the quest for symptom-specific biomarkers.
Sato S; Temmoku J; Fujita Y; Yashiro-Furuya M; Matsuoka N; Asano T; Kobayashi H; Watanabe H; Migita K
Fukushima J Med Sci; 2020 Apr; 66(1):1-9. PubMed ID: 32173681
[TBL] [Abstract][Full Text] [Related]
9. Association of cerebrospinal fluid anti-NR2 glutamate receptor antibodies with diffuse neuropsychiatric systemic lupus erythematosus.
Arinuma Y; Yanagida T; Hirohata S
Arthritis Rheum; 2008 Apr; 58(4):1130-5. PubMed ID: 18383393
[TBL] [Abstract][Full Text] [Related]
10. Serum and cerebrospinal fluid autoantibodies in patients with neuropsychiatric lupus erythematosus. Implications for diagnosis and pathogenesis.
Fragoso-Loyo H; Cabiedes J; Orozco-Narváez A; Dávila-Maldonado L; Atisha-Fregoso Y; Diamond B; Llorente L; Sánchez-Guerrero J
PLoS One; 2008 Oct; 3(10):e3347. PubMed ID: 18836530
[TBL] [Abstract][Full Text] [Related]
11. Update on the pathogenesis of central nervous system lupus.
Nikolopoulos D; Fanouriakis A; Boumpas DT
Curr Opin Rheumatol; 2019 Nov; 31(6):669-677. PubMed ID: 31415031
[TBL] [Abstract][Full Text] [Related]
12. Clinical utility of circulating anti-N-methyl-
Tay SH; Fairhurst AM; Mak A
Autoimmun Rev; 2017 Feb; 16(2):114-122. PubMed ID: 27988431
[TBL] [Abstract][Full Text] [Related]
13. A meta-analysis of serum and cerebrospinal fluid autoantibodies in neuropsychiatric systemic lupus erythematosus.
Ho RC; Thiaghu C; Ong H; Lu Y; Ho CS; Tam WW; Zhang MW
Autoimmun Rev; 2016 Feb; 15(2):124-38. PubMed ID: 26497108
[TBL] [Abstract][Full Text] [Related]
14. Antibodies in patients with neuropsychiatric systemic lupus erythematosus.
Kimura A; Kanoh Y; Sakurai T; Koumura A; Yamada M; Hayashi Y; Tanaka Y; Hozumi I; Takemura M; Seishima M; Inuzuka T
Neurology; 2010 Apr; 74(17):1372-9. PubMed ID: 20421581
[TBL] [Abstract][Full Text] [Related]
15. Systemic lupus erythematosus, the brain, and anti-NR2 antibodies.
Lauvsnes MB; Omdal R
J Neurol; 2012 Apr; 259(4):622-9. PubMed ID: 21909801
[TBL] [Abstract][Full Text] [Related]
16. Absence of Neuronal Autoantibodies in Neuropsychiatric Systemic Lupus Erythematosus.
Varley JA; Andersson M; Grant E; Berretta A; Zandi MS; Bondet V; Duffy D; Hunt D; Piehl F; Waters P; Irani SR
Ann Neurol; 2020 Dec; 88(6):1244-1250. PubMed ID: 32951275
[TBL] [Abstract][Full Text] [Related]
17. Complement levels and anti-C1q autoantibodies in patients with neuropsychiatric systemic lupus erythematosus.
Magro-Checa C; Schaarenburg RA; Beaart HJ; Huizinga TW; Steup-Beekman GM; Trouw LA
Lupus; 2016 Jul; 25(8):878-88. PubMed ID: 27252265
[TBL] [Abstract][Full Text] [Related]
18. Immunological biomarkers in neuropsychiatric systemic lupus erythematosus: a comparative cross-sectional study from a tertiary care center in South India.
Seth G; Sundaresh A; Mariaselvam CM; Kumar G; Chengappa KG; Adarsh MB; Tamouza R; Negi VS
Lupus; 2020 Apr; 29(4):413-420. PubMed ID: 32106787
[TBL] [Abstract][Full Text] [Related]
19. Impact analysis of autoantibody level and NR2 antibody level in neuropsychiatric SLE treated by methylprednisolone combined with MTX and DXM intrathecal injection.
Wang J; Zhao Y; Zhang J; Lei H; Zhu G; Fu B
Cell Biochem Biophys; 2014 Nov; 70(2):1005-9. PubMed ID: 24845150
[TBL] [Abstract][Full Text] [Related]
20. Role of serum autoantibodies in blood brain barrier damages in neuropsychiatric systemic lupus erythematosus.
Hirohata S; Sakuma Y; Matsueda Y; Arinuma Y; Yanagida T
Clin Exp Rheumatol; 2018; 36(6):1003-1007. PubMed ID: 29846157
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
